Loading...
Fluocinolone Acetonide Intravitreal Implant for Treating Recurrent Non-infectious Uveitis: An Evidence Review Group Perspective of a NICE Single Technology Appraisal
The National Institute for Health and Care Excellence (NICE) invited Alimera Sciences, the company manufacturing fluocinolone acetonide intravitreal implant (FAc) 0.19 mg (tradename ILUVIEN(®)), to submit evidence on the clinical and cost-effectiveness of FAc for treating recurrent non-infectious uv...
Na minha lista:
| Udgivet i: | Pharmacoeconomics |
|---|---|
| Main Authors: | , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Springer International Publishing
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7176320/ https://ncbi.nlm.nih.gov/pubmed/31701471 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40273-019-00851-z |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|